Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: A prereceptor determinant of pituitary cell proliferation

Oncogene

Volumn 22, Issue 11, 2003, Pages 1663-1667

  Rabbitt, E H ^a   Ayuk, J ^a   Boelaert, K ^a   Sheppard, M C ^a   Hewison, M ^a   Stewart, P M ^a,b   Gittoes, N J L ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

11 hydroxysteroid dehydrogenase; Pituitary adenoma; Proliferation

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; GLYCYRRHETINIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADENOMA; BASE SEQUENCE; CELL DIVISION; DNA PRIMERS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; PITUITARY NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037456999     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206293     Document Type: Article

References (32)

1. Bamberger CM, Fehn M, Bamberger AM, Ludecke DK, Beil FU, Saeger W and Schulte HM. (1999). Eur. J. Endocrinol., 140, 250-255.
2. Bland R, Worker CA, Noble BS, Eyre LJ, Bujalska IJ, Sheppard MC, Stewart PM and Hewison M. (1999). J. Endocrinol., 161, 455-464.
3. Cooper MS, Walker EA, Bland R, Fraser WD, Hewison M and Stewart PM (2000). Bone, 27, 375-381.
4. Croxtall JD, Choudhury Q and Flower RJ. (2000). Br. J. Pharmacol., 130, 289-298.
5. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K and Roberts JM. (1996). Cell, 85, 733-744.
6. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L and Xiong Y. (1998). Genes Dev., 12, 2899-2911.
7. Gingras MC and Margolin JF. (2000). Exp. Hematol., 28, 350.
8. Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC and Franklyn JA. (1997). J. Clin. Endocrinol. Metab., 82, 1960-1967.
9. Hundertmark S, Buhler H, Rudolf M, Weitzel HK and Ragosch V. (1997). J. Endocrinol., 155, 171-180.
10. Kato JY, Matsuoka M, Polyak K, Massague J and Sherr, CJ. (1994). Cell, 79, 487-496.
11. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA and Koff A. (1996). Cell, 85, 721-732.
12. Korbonits M, Bujalska I, Shimojo M, Nobes J, Jordan S, Grossman AB and Stewart PM. (2001). J. Clin. Endocrinol. Metab., 86, 2728-2733.
13. Koyama K, Myles K, Smith R and Krozowski Z. (2001). J. Steroid Biochem. Mol. Biol., 76, 153-159.
14. Labrie F, Luu-The V, Lin SX, Simard J and Labrie C. (2000). Trends Endocnnol. Metab., 11, 421-427
15. Lidhar K, Korbonits M, Jordan S, Khalimova Z, Kaltsas G, Lu X, Clayton RN, Jenkins PJ, Monson JP, Besser GM, Lowe DG and Grossman AB. (1999). J. Clin. Endocrinol. Metab., 84, 3823-3830.
16. McKay LI and Cidlowski JA. (1999). Endocrine Rev., 20, 435-459.
17. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD and Stewart PM (2001). J. Clin. Endocrinol. Metab., 86, 4979-4983.
18. Motoo Y and Sawabu N. (1994). Cancer Lett., 86, 91-95.
19. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY and Nakayama K. (1996). Cell, 85, 707-720.
20. Nawrocki AR, Goldring CE, Kostadinova RM, Frey FJ and Frey BM. (2002). J. Biol. Chem., 277, 14647-14656.
21. Rabbitt EH, Lavery GG, Walker EA, Cooper MS, Stewart PM and Hewison M. (2002). Faseb J., 16, 36-44.
22. Robson AC, Leckie CM, Seckl JR and Holmes MC. (1998). Brain Res. Mol. Brain Res., 61, 1-10.
23. Rogatsky I, Trowbridge JM and Garabedian MJ. (1997). Mol. Cell Biol., 17, 3181-3193.
24. Samuelsson MK, Pazirandeh A, Davani B and Okret S. (1999). Mol. Endocrinol., 13, 1811-1822.
25. Sanchez I, Goya L, Vallerga AK and Firestone GL. (1993). Cell Growth Differ., 4, 215-225.
26. Shiota G, Harada K, Ishida M, Tomie Y, Okubo M, Katayama S, Ito H and Kawasaki H. (1999). Carcinogenesis, 20, 59-63.
27. Stewart PM and Krozowski ZS. (I999). Vitam. Horm., 57, 249-324.
28. Stewart PM, Krozowski ZS, Gupta A, Milford DV, Howie AJ, Sheppard MC and Whorwood CB. (1996). Lancet, 347, 88-91.
29. Stewart PM and Tomlinson JW. (2002). Trends Endocrinol. Metab., 13, 94-96.
30. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH and Edwards CR. (1987). Lancet, 2, 821-824.
31. White PC, Mune T and Agarwal AK. (1997). Endocrine Rev., 18, 135-156.
32. Whorwood CB, Sheppard MC and Stewart PM. (1993). Endocrinology, 132, 2287-2292.